Zydus Lifescience Q4 Result: Final dividend of Rs 11 per share announced, highest payout in over a decade
The pharmaceutical major posted a consolidated net profit of Rs 1,170.9 crore in Q4 FY25, slightly lower than the Rs 1,182.3 crore reported in the same period last year. Despite the steady earnings, the market reaction was muted — Zydus shares are trading flat at Rs 904.25 apiece on the NSE.
Zydus Lifesciences has announced a final dividend of Rs 11 per share for FY25, its highest-ever in over a decade, making headlines on Dalal Street. The dividend recommendation was approved by the board along with the Q4 earnings declaration on May 20, 2025.
This marks a sharp jump from last year’s final dividend of Rs 6 per share and is nearly three times higher than the Rs 3 dividend paid in FY24. Over the past ten years, Zydus had mostly maintained payouts in the range of Rs 2.50–Rs 6, making this year’s announcement a standout.
The stock may gain attention in the coming sessions, given the dividend yield and payout jump, especially among long-term investors hunting for value in pharma stocks.
Dividend history at a glance:
More to come…
Anurag Dhole is a seasoned journalist and content writer with a passion for delivering timely, accurate, and engaging stories. With over 8 years of experience in digital media, she covers a wide range of topics—from breaking news and politics to business insights and cultural trends. Jane's writing style blends clarity with depth, aiming to inform and inspire readers in a fast-paced media landscape. When she’s not chasing stories, she’s likely reading investigative features or exploring local cafés for her next writing spot.